First Phase 1 Optogenetic Trials Should Be Conducted in People Who Are Dying

ISSN： 2150-7740

Source： AJOB Neuroscience, Vol.5, Iss.3, 2014-07, pp. : 16-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Who should make the decision on the use of GPS for people with dementia?

By Landau Ruth Auslander Gail Werner Shirli Shoval Noam Heinik Jeremia

Aging and Mental Health, Vol. 15, Iss. 1, 2011-01 ,pp. : 78-84

Routledge Ltd

Access to resources Recommend Favorite

Controlling Brain Cells With Light: Ethical Considerations for Optogenetic Clinical Trials

By Gilbert Frederic Harris Alexander R. Kapsa Robert M. I.

AJOB Neuroscience, Vol. 5, Iss. 3, 2014-07 ,pp. : 3-11

Taylor & Francis Ltd

Access to resources Recommend Favorite

Cognitive and behavioural assessment in clinical trials: when should they be done?

By Thompson P.

Epilepsy Research, Vol. 45, Iss. 1, 2001-05 ,pp. : 159-161

Elsevier

Access to resources Recommend Favorite

Cognitive and behavioural assessment in clinical trials: when should they be done?

By Aldenkamp A.P.

Epilepsy Research, Vol. 45, Iss. 1, 2001-05 ,pp. : 155-157

Elsevier

Access to resources Recommend Favorite

The Impact of Expert Testimony in Trials of Battered Women Who Kill

By Schuller R.A.

Psychiatry, Psychology and Law, Vol. 11, Iss. 1, 2004-03 ,pp. : 1-12

Australian Academic Press

Access to resources Recommend Favorite